Answer
Myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML), including fatal cases, have been reported in patients treated with Zejula alone or in combination therapy in clinical trials and postmarketing.
Sources for this answer
- Zejula 100mg TabletsGlaxoSmithKline UK · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked